Beranda › Mieloma Multipel › Missouri › Kansas City
Uji klinis Mieloma Multipel di Kansas City, MO
10 studi untuk Mieloma Multipel mencari peserta di lokasi sekitar Kansas City (dalam radius sekitar 30 mil). Buka studi untuk melihat kriteria peserta dan cara menghubungi tim studi.
Teks studi resmi (Bahasa Inggris)
Merekrut peserta untuk studi di sini? Tampilkan di bagian atas halaman ini — $99 selama 30 hari →
Testing Teclistamab (TECVAYLI) in Combination With Iberdomide for Relapsed or Refractory Multiple Myeloma
Menerima pesertaFase 1
- University of Kansas Hospital-Westwood Cancer Center, Westwood · 5 mi jauhnya
A Long-term Study for Participants Previously Treated With Ciltacabtagene Autoleucel
Menerima pesertaFase 4
- Kansas University Medical Center, Westwood · 5 mi jauhnya
A Study of Teclistamab in Combination With Daratumumab and Lenalidomide (Tec-DR) and Talquetamab in Combination With Daratumumab and Lenalidomide (Tal-DR) in Participants With Newly Diagnosed Multiple Myeloma
Menerima pesertaFase 3
- MidAmerica Cancer Care, Kansas City
Study of Arlocabtagene Autoleucel (BMS-986393) a GPRC5D-directed CAR T Cell Therapy in Adult Participants With Relapsed or Refractory Multiple Myeloma
Menerima pesertaFase 2
- The University of Kansas Cancer Center - Westwood, Westwood · 5 mi jauhnya
A Study of Gammagard Liquid (Immune Globulin Infusion, 10%) to Prevent Infections in Adults With Multiple Myeloma
Menerima pesertaFase 3
- University of Kansas, Westwood · 5 mi jauhnya
MagnetisMM-32: A Study to Learn About the Study Medicine Called Elranatamab in People With Multiple Myeloma (MM) That Has Come Back After Taking Other Treatments (Including Prior Treatment With an Anti-CD38 Antibody and Lenalidomide)
Menerima pesertaFase 3
- Kansas City VA Medical Center, Kansas City
- American Oncology Partners, P.A. Dba MidAmerica Cancer Care, Kansas City
Testing the Use of Combination Therapy in Adult Patients With Newly Diagnosed Multiple Myeloma, the EQUATE Trial
Menerima pesertaFase 3
- Kansas City Veterans Affairs Medical Center, Kansas City
Integrated Cancer Repository for Cancer Research
Menerima pesertaStudi observasionalSukarelawan sehat diterima
- Saint Luke's Cancer Institute, East, Kansas City
- Saint Luke's Cancer Institute, Kansas City
- Saint Luke's Cancer Institute, Kansas City North, Kansas City
- dan 1 lainnya
Comparing Combinations of Drugs to Treat Newly Diagnosed Multiple Myeloma (NDMM) When a Stem Cell Transplant is Not a Medically Suitable Treatment
Menerima pesertaFase 3
- Research Medical Center, Kansas City
Study to Assess Safety and Tolerability of OPN-6602 in Subjects With Relapsed and/or Refractory Multiple Myeloma
Menerima pesertaFase 1
- University of Kansas Clinical Research Center, Westwood · 5 mi jauhnya
Uji klinis Mieloma Multipel di kota lain
- New York City, NY60 studi
- Boston, MA42 studi
- Atlanta, GA42 studi
- Houston, TX38 studi
- Durham, NC37 studi
- Nashville, TN32 studi
- Denver, CO27 studi
- Rochester, MN24 studi
- St. Louis, MO24 studi
- Columbus, OH24 studi
- Baldwin Park, CA23 studi
- Edison, NJ22 studi
Studi lain di Kansas City
- Kanker Payudara34 studi
- Kanker Paru Non-Sel Kecil31 studi
- Gagal Jantung25 studi
- Kanker (semua jenis)21 studi
- Kanker Paru19 studi
- Kanker Kolorektal16 studi
- Kanker Metastatik15 studi
- Leukemia Mieloid Akut15 studi
- Kanker Prostat14 studi
- Kanker Ovarium11 studi
- Obesitas11 studi
- Diabetes Tipe 211 studi
Dari ClinicalTrials.gov, data diambil 6 Okt 2026. Setiap studi menetapkan kriteria kelayakannya sendiri; tim studi yang menentukan siapa yang bisa bergabung.